These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29430799)

  • 1. Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality.
    Wong CKH; Jiao F; Tang EHM; Tong T; Thokala P; Lam CLK
    Diabetes Obes Metab; 2018 Jun; 20(6):1470-1478. PubMed ID: 29430799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of Type 2 Diabetes mellitus in Hong Kong Chinese.
    Chan BS; Tsang MW; Lee VW; Lee KK
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):455-68. PubMed ID: 17725179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
    Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
    Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct medical costs in the preceding, event and subsequent years of a first severe hypoglycaemia episode requiring hospitalization: A population-based cohort study.
    Wong CKH; Tong T; Cheng GHL; Tang EHM; Thokala P; Tse ETY; Lam CLK
    Diabetes Obes Metab; 2019 Jun; 21(6):1330-1339. PubMed ID: 30737873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus.
    Wu T; Yang F; Chan WWL; Lam CLK; Wong CKH
    J Diabetes Investig; 2020 Nov; 11(6):1661-1672. PubMed ID: 32471010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cost analysis of diagnostic screening for the differentiation of type-1 and type-2 diabetics aged 30 to 45. A health economics modelling calculation].
    Kilburg A; Bruchhausen Y; Thomas J; Rychlik R
    Dtsch Med Wochenschr; 1999 Dec; 124(50):1510-7. PubMed ID: 10633777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Health-Care Costs and Productivity Costs Associated With Hypoglycemia in Adults With Type 1 and Type 2 Diabetes Mellitus That Participated in the Canadian Hypoglycemia Assessment Tool Program.
    O'Reilly DJ; Burke N; Tarride JE; Hahn J; Nurkanovic L
    Can J Diabetes; 2018 Dec; 42(6):659-663. PubMed ID: 29885881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002-2011.
    Williams JS; Bishu K; Dismuke CE; Egede LE
    BMC Health Serv Res; 2017 Apr; 17(1):259. PubMed ID: 28399859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Direct costs of medical care for patients with type 2 diabetes mellitus in Mexico micro-costing analysis].
    Rodríguez Bolaños Rde L; Reynales Shigematsu LM; Jiménez Ruíz JA; Juárez Márquezy SA; Hernández Ávila M
    Rev Panam Salud Publica; 2010 Dec; 28(6):412-20. PubMed ID: 21308167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
    Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.
    Bickston SJ; Waters HC; Dabbous O; Tang BI; Rahman M
    J Manag Care Pharm; 2008 May; 14(4):352-62. PubMed ID: 18500913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM).
    Jiao FF; Fung CSC; Wan EYF; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
    Diabetes Care; 2018 Feb; 41(2):250-257. PubMed ID: 29246949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year cost-effectiveness of the Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care.
    Lian J; McGhee SM; So C; Chau J; Wong CKH; Wong WCW; Lam CLK
    Diabetes Obes Metab; 2017 Sep; 19(9):1312-1316. PubMed ID: 28230312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of diabetes mellitus for medicare beneficiaries.
    Costantino ME; Stacy JN; Song F; Xu Y; Bouchard JR
    Popul Health Manag; 2014 Oct; 17(5):272-8. PubMed ID: 24865764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of known diabetes mellitus in Spain].
    Hart WM; Espinosa C; Rovira J
    Med Clin (Barc); 1997 Sep; 109(8):289-93. PubMed ID: 9379750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.